Massachusetts Financial Services Co. MA Raises Stock Holdings in Definitive Healthcare Corp. (NASDAQ:DH)

Massachusetts Financial Services Co. MA lifted its holdings in shares of Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 76.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,466,514 shares of the company's stock after acquiring an additional 1,496,652 shares during the quarter. Massachusetts Financial Services Co. MA owned 2.98% of Definitive Healthcare worth $34,457,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Conestoga Capital Advisors LLC grew its position in shares of Definitive Healthcare by 12.1% during the 4th quarter. Conestoga Capital Advisors LLC now owns 5,521,137 shares of the company's stock valued at $54,880,000 after acquiring an additional 595,280 shares during the period. Vanguard Group Inc. increased its position in Definitive Healthcare by 6.2% in the third quarter. Vanguard Group Inc. now owns 4,331,543 shares of the company's stock worth $34,609,000 after buying an additional 254,726 shares during the last quarter. Bank of New York Mellon Corp raised its stake in shares of Definitive Healthcare by 11.7% in the third quarter. Bank of New York Mellon Corp now owns 1,090,136 shares of the company's stock valued at $8,710,000 after buying an additional 113,963 shares during the period. Eagle Asset Management Inc. lifted its position in shares of Definitive Healthcare by 7.5% during the 3rd quarter. Eagle Asset Management Inc. now owns 784,230 shares of the company's stock valued at $6,266,000 after buying an additional 54,590 shares during the last quarter. Finally, Raymond James & Associates grew its stake in shares of Definitive Healthcare by 24.2% during the 3rd quarter. Raymond James & Associates now owns 650,327 shares of the company's stock worth $5,196,000 after acquiring an additional 126,613 shares during the period. 98.67% of the stock is currently owned by institutional investors.

Definitive Healthcare Stock Performance

Shares of NASDAQ:DH remained flat at $5.50 during trading on Friday. 690,582 shares of the stock were exchanged, compared to its average volume of 1,116,758. Definitive Healthcare Corp. has a 1 year low of $4.38 and a 1 year high of $12.45. The company has a market capitalization of $648.62 million, a PE ratio of -3.14, a P/E/G ratio of 4.74 and a beta of 1.41. The firm's 50-day moving average price is $7.24 and its 200-day moving average price is $8.24. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.30 and a current ratio of 2.30.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last released its quarterly earnings data on Wednesday, February 28th. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.01 by ($0.02). Definitive Healthcare had a negative net margin of 78.16% and a positive return on equity of 0.51%. The business had revenue of $65.93 million for the quarter, compared to analysts' expectations of $66.01 million. Sell-side analysts expect that Definitive Healthcare Corp. will post 0.1 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on DH. Deutsche Bank Aktiengesellschaft decreased their price objective on Definitive Healthcare from $10.00 to $7.00 and set a "hold" rating on the stock in a research note on Thursday, May 9th. Barclays reduced their price target on shares of Definitive Healthcare from $11.00 to $7.00 and set an "equal weight" rating on the stock in a research report on Thursday, May 9th. William Blair reiterated an "outperform" rating on shares of Definitive Healthcare in a report on Tuesday. Canaccord Genuity Group cut their target price on shares of Definitive Healthcare from $10.00 to $8.00 and set a "hold" rating on the stock in a report on Wednesday, May 8th. Finally, Stifel Nicolaus lowered their price target on shares of Definitive Healthcare from $11.00 to $9.50 and set a "buy" rating for the company in a report on Wednesday, May 8th. Nine research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $9.94.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.